Alexion Pharmaceuticals, Inc.

Q1 2018 13F Holders

Symbol
ALXN
CUSIP
015351109
Type
Equity
Class
COM
Num filings
656
Total reported value, excl. options
$23.6 B
Manager Report Date Value ($000) Shares Option Type